![Fortunato Rocca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Fortunato Ron Rocca is currently the President & Chief Executive Officer at MiNDERA Corp.
He is also serving as an Independent Director at Interpace Biosciences, Inc. and as a Director at Circular Genomics, Inc. Previously, he held the positions of President, Chief Executive Officer & Director at Exagen, Inc. from 2011 to 2022.
He also worked as a Marketing Director at Elan Pharmaceuticals LLC from 1998 to 2004 and as the Chief Operating Officer at Zoetis Products LLC from 2004 to 2005.
Additionally, he served as the General Manager, Vice President-Sales & Marketing at Prometheus Laboratories, Inc. from 2005 to 2011.
Mr. Rocca has a background in undergraduate studies from Towson University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INTERPACE BIOSCIENCES, INC. | Director/Miembro de la Junta | 22/01/2020 |
Circular Genomics, Inc.
 Circular Genomics, Inc. BiotechnologyHealth Technology Operates as a biotechnology and genomics company that develops RNA-based diagnostics and therapeutics | Director/Miembro de la Junta | 17/08/2023 |
MiNDERA Corp.
 MiNDERA Corp. Medical/Nursing ServicesHealth Services Provides healthcare services | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| EXAGEN INC. | Director Ejecutivo | 16/10/2022 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Ventas & Marketing | 01/10/2011 |
Zoetis Products LLC
 Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Director de Operaciones | 01/05/2005 |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Ventas & Marketing | 01/01/2004 |
Alpharma LLC
 Alpharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Zoetis Products LLC
Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Interpace Biosciences, Inc.
 Interpace Biosciences, Inc. Medical SpecialtiesHealth Technology Provides commercialization services to biopharmaceutical companies | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
MiNDERA Corp.
MiNDERA Corp. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Towson University
 Towson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Exagen, Inc.
 Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
Alpharma LLC
Alpharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Circular Genomics, Inc.
Circular Genomics, Inc. BiotechnologyHealth Technology Operates as a biotechnology and genomics company that develops RNA-based diagnostics and therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
